The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

Council of Economic Advisors Chair Stephen Miran discusses the significance of the 'big, beautiful bill' on 'Kudlow.' ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...